If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 51 - 60 of 275
A Phase 2 , Open-Label, Multicenter, Randomized Study Evaluating Neoadjuvant Therapy Targeting the Adenosine Immunosuppressive Pathway in Combination with Immune Checkpoint Blockade and Radiation Therapy in Patients with Advanced PANCreatic Ductal Ad
Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma (AIRPanc)
Protocol No
COLUMBIA-AAAU4206-AIRPANC
Categories
Radioembolization Oncology Trial Utilizing Transarterial Eye90 (ROUTE 90) for the Treatment of Hepatocellular Carcinoma (HCC)
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
Protocol No
ABK-CA-PROT-85
Categories
A First-in-Human, Multicenter, Phase 1, Open-Label Study of XTX301 in Patients with Advanced Solid Tumors
A First-in-Human, Open-Label Study of XTX301 in Patients with Advanced Solid Tumors
Protocol No
XILIO-XTX301-01-02-001
Transgender Care Research Study
Transgender Ensemble Project
Protocol No
PLS-IIT-DOREN-TRANS-ENSEMBLE
Categories
MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer
Testing the role of DNA released from tumor cells into the blood in guiding the use of immunotherapy after surgical removal of the bladder for bladder cancer treatment.
Protocol No
ALLIANCE-A032103-MODERN
Categories
A Pre-Pilot Study to Understand the Feasibility of Implementing a Wearable Device Cueing System Following Bone Marrow Transplant
The BMT Wearables Pre-Pilot
Protocol No
IIT-MORELLI-BMT-WEARABLES
Categories
A Prospective Study Evaluating Maternal and Fetal Outcomes in the Era of Modulators (MAYFLOWERS)
Prospective Study of Pregnancy in Women With Cystic Fibrosis
Protocol No
PULM-CFF-MAYFLOWERS-OB-20
Categories
A Phase Ib Study of Combination Atr (M1774) and Bet Inhibition (Zen003694) To Exploit Arid1a Loss in Recurrent Ovarian and Endometrial Cancer
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Protocol No
NRG-GY031
Categories
A Phase 1/1b Study of ASP2138 in Participants with Metastatic or Locally Advanced Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma or Metastatic Pancreatic Adenocarcinoma Whose Tumors Have Claudin (CLDN) 18.2 Expression
ASP2138 in Adults With Stomach Cancer or Pancreatic Cancer
Protocol No
ASTELLAS-2138-CL-0101
Categories
An Open-Label, Phase 1, Multi-Center Study to Evaluate the Safety and Preliminary Anti-Tumor Activity of NT-112 in Human Leukocyte Antigen-C*08:02-Positive Adult Subjects with Unresectable, Advanced and/or Metastatic Solid Tumors That Are Positive fo
A Phase1 Study of NT-112 in Patients with Advanced Solid Tumors Positive for KRAS G12D Mutation
Protocol No
NEOGENE-NT-112-301
Categories